Cannara Biotech【LOVE】銘柄情報

Cannara Biotech Inc (LOVE) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

1.64

( -1.80% )

買値

1.62

売値

1.64

出来高

27,208

1.61 日の範囲 1.67

1.58 52 週間の範囲 2.05

時価総額

162.003M

前日終値

1.67

始値

1.63

時刻

500

1.64

最終取引時間

04:05:42

財務取引量

VWAP

平均取引量 (3 か月)

$ 42,870

発行済株式数

98,782,148

配当利回り

PER

15.45

1 株当たり利益 (EPS)

0.11

歳入

113.01M

純利益

10.16M

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORC... Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. 詳細を表示

セクター

業界

ウェブサイト

cannara.ca

本社

Saint-laurent, Canada

設立

2026

Cannara Biotech Inc is listed in the sector of the トロント証券取引所 with ticker LOVE. The last closing price for Cannara Biotech was $1.67. Over the last year, Cannara Biotech shares have traded in a share price range of $ 1.58 to $ 2.05.

Cannara Biotech currently has 98,782,148 shares in issue. The market capitalisation of Cannara Biotech is $162 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 15.45.

Cannara Completes Acquisition of Medican Organic Inc.

MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”...

Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec

Delivered strong Q2 financial results: Generated $27.2 million in total net revenues, $11.6 million in gross...

Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026

MONTREAL, April 07, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.03	-1.79640718563	1.67	1.7	1.58	49247	1.65798394	CS
4	-0.06	-3.52941176471	1.7	1.75	1.58	31238	1.68838399	CS
12	-0.16	-8.88888888889	1.8	2.05	1.58	44817	1.78965261	CS
26	-0.26	-13.6842105263	1.9	2.05	1.58	40801	1.79369672	CS
52	-0.26	-13.6842105263	1.9	2.05	1.58	40801	1.79369672	CS
156	-0.26	-13.6842105263	1.9	2.05	1.58	40801	1.79369672	CS
260	-0.26	-13.6842105263	1.9	2.05	1.58	40801	1.79369672	CS